loadpatents
name:-0.022445917129517
name:-0.015200138092041
name:-0.001276969909668
Nielsen; Ole Patent Filings

Nielsen; Ole

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nielsen; Ole.The latest application filed is for "transport and storage system for servicing of a number of treatment and care areas in a hospital and method for operation hereof".

Company Profile
0.14.20
  • Nielsen; Ole - Aalborg DK
  • NIELSEN; Ole - Valby DK
  • Nielsen; Ole - Randers DK
  • Nielsen; Ole - Herlev DK
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Transport and storage system for servicing of a number of treatment and care areas in a hospital and method for operation hereof
Grant 10,219,964 - Grigoriou , et al.
2019-03-05
Transport And Storage System For Servicing Of A Number Of Treatment And Care Areas In A Hospital And Method For Operation Hereof
App 20180036192 - GRIGORIOU; Niki Nicolas ;   et al.
2018-02-08
Process For The Manufacture Of Idalopirdine
App 20160168089 - JACOBSEN; Mikkel Fog ;   et al.
2016-06-16
Crystalline forms of a pharmaceutical compound
Grant 8,729,065 - Rock , et al. May 20, 2
2014-05-20
Processes for 4-((1R,35)-6-Chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine or a salt thereof
Grant 8,227,607 - de Diego , et al. July 24, 2
2012-07-24
Crystalline forms of a pharmaceutical compound
Grant 8,076,320 - Rock , et al. December 13, 2
2011-12-13
Malonate salt of 4-((1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and uses of same
Grant 8,076,342 - Lopez de Diego , et al. December 13, 2
2011-12-13
Crystalline Forms of a Pharmaceutical Compound
App 20110124629 - Rock; Michael Harold ;   et al.
2011-05-26
Method For The Preparation Of Escitalopram
App 20110065938 - Sommer; Michael B. ;   et al.
2011-03-17
Malonate Salt Of 4-((1r,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine And Uses Of Same
App 20110053957 - Lopez de Diego; Heidi ;   et al.
2011-03-03
Crystalline Base Of Escitalopram And Orodispersible Tablets Comprising Escitalopram Base
App 20110046218 - Dancer; Robert ;   et al.
2011-02-24
Processes For 4-((1r,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine Or A Salt Thereof
App 20100324291 - Lopez de Diego; Heidi ;   et al.
2010-12-23
Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
Grant 7,834,201 - Dancer , et al. November 16, 2
2010-11-16
Hydrogen succinate salts of trans-4-((1R, 3S)-6-chloro-3-phenylindan-1-YL)-1,2,2-trimethylpiperazine and the use as a medicament
Grant 7,767,683 - Lopez de Diego , et al. August 3, 2
2010-08-03
Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
Grant 7,723,533 - Dancer , et al. May 25, 2
2010-05-25
Crystalline base of escitalopram and orodispersible tablets comprising escitalopram base
Grant 7,560,576 - Dancer , et al. July 14, 2
2009-07-14
Tartrate and Malate Salts of Trans-1-((1R,3S)-6-Chloro-3-Phenylindan-1-Yl)-3,3-Dimethylpiperazine
App 20080269248 - Nielsen; Ole ;   et al.
2008-10-30
Crystalline Base Of Escitalopram And Orodispersible Tablets Comprising Escitalopram Base
App 20080161388 - Dancer; Robert ;   et al.
2008-07-03
Crystalline Base Of Escitalopram And Orodispersible Tablets Comprising Escitalopram Base
App 20080161584 - Dancer; Robert ;   et al.
2008-07-03
Crystalline forms of a pharmaceutical compound
App 20070191339 - Rock; Michael Harold ;   et al.
2007-08-16
Crystalline Base Of Escitalopram And Orodispersible Tablets Comprising Escitalopram Base
App 20070021499 - Dancer; Robert ;   et al.
2007-01-25
Succinate and malonate salt of trans 4-(ir,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament
App 20060281759 - de Diego; Heidi Lopez ;   et al.
2006-12-14
Process for the preparation of racemic citalopram and/or S-or R-citalopram by separation of a mixture of R-and S-citalopram
Grant 7,112,686 - Humble , et al. September 26, 2
2006-09-26
1'-[4-[1-(4-fluorophenyl)-1H-indole-3-Y1]-spiro[isobenzofuran-1(3H), 4'-piperidine]hydrohalogenides
App 20050171135 - Mork, Niels ;   et al.
2005-08-04
Method for the preparation of escitalopram
App 20050065207 - Sommer, Michael B ;   et al.
2005-03-24
Pharmaceutical composition containing citalopram
App 20050053652 - Liljegren, Ken ;   et al.
2005-03-10
1'-[4-[1-(4-fluorophenyl)-1H-indole-3-yl]-1-butyl]-spiro[isobenzofuran-1(3H ),4'-piperidine] hydrohalogenides
Grant 6,844,352 - M.o slashed.rk , et al. January 18, 2
2005-01-18
Process for the preparation of racemic citalopram and/or s-or r-citalopram by separation of a mixture of r-and s-citalopram
App 20040259940 - Humble, Rikke E. ;   et al.
2004-12-23
Crystals of pharmaceutically acceptable salts of citalopram, methods of crystallization, and pharmaceutical compositions comprising them
App 20030232881 - Liljegren, Ken ;   et al.
2003-12-18
Pharmaceutical composition containing citalopram
App 20030109577 - Liljegren, Ken ;   et al.
2003-06-12
1'-[4-[1-(4-fluorophenyl)-1H-indole-3-yl]-1-butyl]-spiro[isobenzofuran-1(3- H),4'-piperidine] hydrohalogenides
App 20030055074 - Mork, Niels ;   et al.
2003-03-20
Carriage body
Grant 6,327,981 - N.o slashed.rregaard , et al. December 11, 2
2001-12-11
Measuring chamber unit
Grant 4,160,714 - Andersen , et al. July 10, 1
1979-07-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed